Gene and drug delivery system with soluble inorganic carriers

NanoBioTechnology: BioInspired Devices and Materials of the Future

Volumn , Issue , 2008, Pages 349-367

  Choy, Jin Ho ^a   Park, Man ^a   Oh, Jae Min ^a  

^a Ewha Womans University   (South Korea)

Author keywords

Antisense; bio LDH hybrids; inoganic organic hybrids; layered double hydroxides (LDH); methotrexate

Indexed keywords

EID: 84888640273     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-218-2_14     Document Type: Chapter

References (37)

1. Carretero MI. Clay minerals and their beneficial effects upon human health. A review. Appl Clay Sci 2002;21:155-163.
2. Lin FH, Lee YH, Jian CH, Wong JM, Shieh MJ, Wang CY. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials 2002;23:1981-1987.
3. Ito T, Sugafuji T, Maruyama M, Ohwac Y, Takahashic T. Skin penetration by indomethacin is enhanced by use of an indomethacin/smectite complex. J Supramol Chem 2001;1:217-219.
4. Lee WF, Fu YT. Effect of montmorillonite on the swelling behavior and drug-release behavior of nanocomposite hydrogels. J Appl Polym Sci 2003;89: 3652-3660.
5. Choy JH, Kwak SY, Park JS, Jeong YJ, Portier J. Intercalative nanohybrids of nucleoside monophosphates and DNA in layered metal hydroxide. J Am Chem Soc 1999;121:1399-1400.
6. Choy JH, Kwak SY, Jeong YJ, Park JS. Inorganic layered double hydroxides as nonviral vectors. Angew Chem Int Ed Engl 2000;39:4041-4045.
7. Choy JH, Park JS, Kwak SY, Jeong YJ, Han YS. Layered double hydroxide as gene reservoir. Mol Cryst Liq Cryst Sci Technol, Sect A 2000;341:1229-1233.
8. Choy JH, Kwak SY, Park JS, Jeong YJ. Cellular uptake behavior of [gamma-P-32] labeled ATP-LDH nanohybrids. J Mater Chem 2001;11:1671-1674.
9. Choy JH, Jung JS, Oh JM, et al. Layered double hydroxide as an efficient drug reservoir for folate derivatives. Biomaterials 2004;25:3059-3064.
10. Choy JH, Son YH. Intercalation of vitamer into LDH and their controlled release properties. Bull Kor Chem Soc 2004;25:122-126.
11. Choy JH, Oh JM, Choi SJ. Nanoceramics-biomolecular conjugates for gene and drug delivery. Adv Sci Tech 2006;45:769-778.
12. Choy JH, Park M, Oh JM. Bio-nanohybrids based on layered double hydroxide. Curr Nanosci 2006;2:275-281.
13. Oh JM, Choi SJ, Kim ST, Choy JH. Cellular uptake mechanism of an inorganic nanovehicle and its drug conjugates: enhanced efficacy due to clathrin-mediated endocytosis. Bioconjugate Chem 2006;17:1411-1417.
14. Oh JM, Kwak SY, Choy JH. Intracrystalline structure of DNA molecules stabilized in the layered double hydroxide. J Phys Chem Solids 2006;67: 1028-1031.
15. Oh JM, Park M, Kim ST, Jung JY, Kang YG, Choy JH. Efficient delivery of anticancer drug MTX through MTX-LDH nanohybrid system. J Phys Chem Solids 2006;67:1024-1027.
16. Choy JH, Choi SJ, Oh JM, Park T. Clay minerals and layered double hydroxides for novel biological applications. Appl Clay Sci 2007;36:122-132.
17. Kwak SY, Jeong YJ, Park JS, Choy JH. Bio-LDH nanohybrid for gene therapy. Solid State Ionics 2002;151:229-234.
18. Yang JH, Lee SY, Han YS, Park KC, Choy JH. Efficient transdermal penetration and improved stability of L-ascorbic acid encapsulated in an inorganic nanocapsule. Bull Kor Chem Soc 2003;24:499-503.
19. Hwang SH, Han YS, Choy JH. Intercalation of functional organic molecules with pharmaceutical, cosmeceutical and nutraceutical functions into layered double hydroxides and zinc basic salts. Bull Kor Chem Soc 2001;22:1019-1022.
20. Khan AI, O'Hare D. Intercalation chemistry of layered double hydroxides: recent developments and applications. J Mater Chem 2002;12:3191-3198.
21. Cavani F, Trifirò F, Vaccari A. Hydrotalcite-type anionic clays: Preparation, properties and applications. Catal Today 1991;11:173-301.
22. 2)O (M3+: Al3+, Ga3+, Fe3+, and Sc3+) by X-ray powder diffraction. J Solid State Chem 2002;167:137-144.
23. 2O Acta Cryst B 1970;26:860-863.
24. Morioka H, Tagaya H, Karasu M, Kadokawa JI, Chiba K. Preparation of hydroxy double salts exchanged by organic compounds. J Mater Res 1998;13:848-851.
25. Meyn M, Beneke K, Lagaly G. Anion-exchange reactions of hydroxy double salts. Inorg Chem 1993;32:1209-1215.
26. Bennet CF, Chiang MY, Chan H, Shoemaker JEE, Mirabelli CK. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol 1992;41:1023-1033.
27. Wu G Y, Wu CH. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem 1987;262:4429-4432.
28. Zanta MA, Boussif O, Adib A, Behr JP. In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. Bioconjug Chem 1997;8:839-844.
29. Choksakulnimitr S, Masuda S, Tokuda H, Takakura Y, Hashida M. In-vitro cytotoxicity of macromolecules in different cell-culture systems. J Controlled Release 1995;34:233-241.
30. Brazeau GA, Attia S, Poxon S, Hughes JA. In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery. Pharm Res 1998;15: 680-684.
31. Putnam D, Langer R. Poly(4-hydroxy-L-proline ester): low-temperature poly-condensation and plasmid DNA complexation. Macromolecules 1999;32: 3658-3662.
32. Guy-Caffey JK, Bodepudi V, Bishop JS, Jayaraman K, Chaudhary N. Novel polyaminolipids enhance the cellular uptake of oligonucleotides. J Biol Chem 1995;270:31, 391-31, 396.
33. Hitchings GH, Smith SL. Dihydrofolate reductases as targets for inhibitors. Adv Enz Regul 1980;18:349-371.
34. Bertino JR. Karnofsky memorial lecture. Ode to methotrexate. J Clin Oncol 1993;11:5-14.
35. Bielack SS, Kempf-Bielack B, Heise U, Schwenzer D, Winkler K. Combined modality treatment for osteosarcoma occurring as a second malignant disease. J Clin Oncol 1999;17:1164-1174.
36. Eksborg S, Alberioni F, Rask C, Beck O, Palm C, Schroeder H, Peterson C. Methotrexate plasma pharmacokinetics: importance of assay method Cancer Lett 1996;108:163-169.
37. Genestier L, Paillot R, Quemeneur L, Izeradjene K, Revillard JP Mechanisms of action of methotrexate. Immunopharmacology 2000;47:247-257.